About the Medicines Committee
The Medicines Committee at Chelsea and Westminster Hospital NHS Foundation Trust is a key clinical governance committee that provides oversight of all matters relating to the safe, effective and economical use of medicines within the organization. As part of the NHS Foundation Trust's commitment to clinical excellence and patient safety, the committee ensures that all medicines management practices align with national standards, regulatory requirements, and best practice guidelines.
The committee operates within the framework established by the National Institute for Health and Care Excellence (NICE), the Care Quality Commission (CQC), and other relevant regulatory bodies. It works collaboratively with clinical teams across the Trust to develop evidence-based policies and procedures that promote safe prescribing, dispensing, administration and monitoring of medicines.
Chelsea and Westminster Hospital NHS Foundation Trust serves a diverse population across North West London, including significant communities with varying healthcare needs. The Medicines Committee takes into account these demographic considerations when developing medicines management strategies, ensuring equitable access to appropriate treatments while maintaining fiscal responsibility.
In recent years, the committee has adapted to meet new challenges including digital transformation in healthcare, antimicrobial stewardship requirements, and the need to implement rapidly evolving treatment modalities. This forward-looking approach ensures the Trust remains at the forefront of innovative medicines management while maintaining the highest safety standards.
Committee Structure
The Medicines Committee reports to the Clinical Governance Committee and has representation from all clinical divisions within the Trust. The multidisciplinary composition ensures that medicines management decisions consider diverse perspectives and expertise.
The committee structure includes several subcommittees and working groups that focus on specific aspects of medicines management, including the Drugs and Therapeutics Committee, Antimicrobial Management Team, and Clinical Pharmacology Advisory Group. This specialized structure allows for in-depth exploration of complex issues while maintaining alignment with the overall strategic direction of the Medicines Committee.
Dr. Sarah Johnson
Dr. Johnson has over 15 years experience in NHS clinical pharmacology and leads the committee with expertise in therapeutic drug monitoring and adverse drug reaction management.
James Mitchell
James oversees pharmaceutical services across the Trust and provides operational leadership for medicines management initiatives.
Dr. Amira Patel
Dr. Patel provides medical governance oversight and ensures alignment with broader clinical strategy.
Lisa Chen
Lisa represents nursing perspectives on medicines administration, patient education, and safety monitoring.
Dr. Robert Williams
Dr. Williams provides expertise on acute care prescribing and medicine management for complex medical conditions.
Priya Sharma
Priya ensures financial considerations are balanced with clinical requirements in medicines procurement decisions.
Key Responsibilities
- Developing and maintaining the Trust's Formulary a list of medicines approved for use within the organization
- Monitoring medicine safety incidents and implementing preventative measures
- Establishing policies for prescribing, dispensing, administration and monitoring of medicines
- Providing guidance on the introduction of new medicines and managing associated risks
- Overseeing antimicrobial stewardship to address antimicrobial resistance
- Ensuring compliance with relevant legislation, including the Human Medicines Regulations 2012
- Supporting the implementation of shared decision-making around medicines with patients
- Monitoring and managing the medicines budget to ensure cost-effective use
- Providing education and training for healthcare professionals on medicines management
- Liaising with regional and national medicines management networks and committees
- Auditing prescribing practice against agreed standards and guidelines
- Overseeing clinical trials involving investigational medicinal products
- Developing and implementing technology-enabled medicines management systems
Recent Updates
New Digital Prescribing System Roll-out
Trust successfully implements electronic prescribing and medicines administration system across all inpatient areas, improving patient safety and clinical efficiency.
Antimicrobial Stewardship Recognition
The Trust's antimicrobial management team receives commendation for innovative approaches to reducing antimicrobial resistance while maintaining patient outcomes.
Patient Information Initiative Launched
New multimodal patient education resources introduced to improve medicines literacy and support shared decision-making about treatment options.
Key Documents
Trust Medicines Policy
Comprehensive policy outlining the governance framework for medicines management across the Trust.
Adult Formulary
Current list of approved medicines for adult patients with prescribing guidelines and formulary restrictions.
Paediatric Formulary
Specialized formulary for paediatric patients with age-specific prescribing guidance.
Antimicrobial Prescribing Guidelines
Evidence-based guidance for appropriate antimicrobial use across all clinical specialties.
High Risk Medicines Management Policy
Specific protocols for the safe handling and administration of high-risk medicines including anticoagulants, opioids and insulin.
Medicines Safety Annual Report 2022-23
Comprehensive review of medicines safety incidents, learning points and improvement actions from the previous year.
Meeting Schedule
The Medicines Committee meets bi-monthly to review medicines management issues, approve policy changes, and monitor implementation of action plans. Additional extraordinary meetings may be convened as needed to address urgent matters.
| Date | Time | Location | Key Agenda Items |
|---|---|---|---|
| January 12, 2024 | 2:00pm - 4:30pm | Clinical Governance Room, Main Hospital | Annual review of high-alert medicines, 2024 strategic planning |
| March 8, 2024 | 2:00pm - 4:30pm | Clinical Governance Room, Main Hospital | Formulary update approval, antibiotic stewardship report |
| May 10, 2024 | 2:00pm - 4:30pm | Clinical Governance Room, Main Hospital | Digital prescribing system evaluation, patient safety metrics review |
| July 12, 2024 | 2:00pm - 4:30pm | Clinical Governance Room, Main Hospital | Annual medicines safety report, quarterly budget review |
| September 13, 2024 | 2:00pm - 4:30pm | Clinical Governance Room, Main Hospital | Winter plan medicines provisions, flu vaccination program update |
| November 8, 2024 | 2:00pm - 4:30pm | Clinical Governance Room, Main Hospital | Formulary exceptional request process review, annual report preparation |
Meeting papers are available for review five working days prior to each meeting. Minutes are published within ten working days following each meeting and available through the Trust governance portal.
Contact Information
Medicines Management Team
Pharmacy Department
Chelsea and Westminster Hospital
369 Fulham Road
London SW10 9NH
General Enquiries
Email: medicines.committee@chelwest.nhs.uk
Phone: 020 3315 5555 ext. 1234
Committee Secretariat
Emily Davies
Email: emily.davies@chelwest.nhs.uk
Phone: 020 3315 5555 ext. 5678
